Phase II Trial Of Interferon In Combination With Thalidomide For Metastatic Renal Cell Carcinoma

... UroToday.com - Both thalidomide and a-interferon (IFN) have been utilized as monotherapy in the treatment of patients with metastatic renal cell carcinoma (RCC), each with modest evidence of activity and acceptable toxicity profiles. One can only wonder as to the relevance of these agents as treatment options, in the era of targeted therapy for patients with metastatic RCC. [click link for full article] ...